Idenix Pharmaceuticals (IDIX) accounted for a 6.25% position in Baupost’s fourth quarter portfolio. The hedge fund increased its stock holdings in Idenix last month from 36,910,868 shares at the end of December 2013. The fund disclosed ownership of 53,331,109 shares, or around a 35% stake in Idenix, in a 13D filing.
Game on, Gilead.
Not useless drivel at all.
Just informing the public that GILD may be guilty of more than greed.
Some people here need an EDUCATION
were born from the same DNA.
Now VRUS, also known as Pharmassett ( as in the word Pharmaceautical Asset ), was just a split off from IDIX.
Ya see, the real owners/inventors of this technology is IDIX.- and the French team led by Sammadossi.
Now Seth Klarman ( Baupost )with his 30 billion, has all the money and the time in the world to see this through.
So IDIX cannot be bled out with time, because they have a bank ( Klarman ) backing them
This may take years, but eventually, truth, justice and the French will prevail.
Good Pulitizer Prize for an investigative journalist.
It is a Pulitizer ready for the taking.
We shall see
As opposed to you
I actually understand how the drug works
and I have read the patents